Background: Exposure to traffic-related particulate matter promotes asthma and allergic diseases. However, the precise cellular and molecular mechanisms by which particulate matter exposure acts to mediate these effects remain unclear.
Methods: We used in vitro cell-culture assays with lung-derived antigen-presenting cells and allergen-specific T cells and in vivo mouse models of allergic airway inflammation with myeloid lineage-specific gene deletions, cellular reconstitution approaches, and antibody inhibition studies. Results: We identified lung alveolar macrophages (AM) as the key cellular target of UFP in promoting airway inflammation. Aryl hydrocarbon receptor-dependent induction of Jagged 1 (Jag1) expression in AM was necessary and sufficient for augmentation of allergic airway inflammation by UFP. UFP promoted T H 2 and T H 17 cell differentiation of allergen-specific T cells in a Jag1-and Notch 4-dependent manner. Treatment of mice with an anti-Notch 4 antibody abrogated exacerbation of allergic airway inflammation induced by UFP. Conclusion: UFP exacerbate allergic airway inflammation by promoting a Jag1-Notch 4-dependent interaction between AM and allergen-specific T cells, leading to augmented T H cell differentiation. (J Allergy Clin Immunol 2018;142:1243-56.)
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It is well appreciated that exposure to air pollution, especially particulate matter (PM) emitted by combustion sources, plays an important role in the increased incidence and prevalence of asthma in recent decades. [1] [2] [3] [4] [5] [6] Among air pollutants, exposure to PM shows the strongest correlation with adverse respiratory health effects. [7] [8] [9] [10] These particles have been shown to promote T H 2 and T H 17 cell responses and upregulate IgE production in the exposed host. [11] [12] [13] [14] [15] Inhaled PM exhibits differential airway penetrance that stratifies according to size. Unlike coarse particles (> _2.5 mm in diameter) trapped in the nasopharyngeal region, fine particles (FP; < _2.5 mm in diameter) and ultrafine particles (UFP; < _0.2 mm in diameter) are able to penetrate into the lower respiratory tract, where they are taken up by antigen-presenting cells (APCs) to mediate local and systemic inflammation. 16 PM modulation of APC function might be particularly relevant to the adjuvant-like effect of PM in promoting immune responses to allergens. 13, 17 Our recent studies have identified a key mechanism common to both UFP and FP by which they augment allergic responses, involving their induction of the Notch receptor ligand Jagged 1 (Jag1) on APCs. 15 This induction is mediated by activation by PM-associated polycyclic aromatic hydrocarbons (PAHs) of the aryl hydrocarbon receptor (AhR), which in turn mediates the transcriptional activation of Jag1. Jag1 engages Notch receptors on allergen-specific T cells, leading to their augmented differentiation into disease-promoting T H cells. These studies did not precisely identify the relevant APC species involved in this process or the target Notch receptor or receptors mediating the response to PM-induced Jag1.
Lung macrophages have been implicated previously in the uptake of and response to PM. [18] [19] [20] They include 2 major subsets: alveolar macrophages (AM) expressing high levels of the b 2 -integrin CD11c (CD11c hi ) and interstitial macrophages (IM) expressing intermediate levels of CD11c (CD11c int ). 21, 22 Studies have shown that both populations promote immune tolerance at steady state by inducing naive T cell/regulatory T (Treg) cell differentiation. 23, 24 However, inflammatory stimuli, including allergens and endotoxin, modulate the expression of costimulation molecules and alter the potency of lung macrophage as APCs. 25, 26 In a similar vein exposure of AM to PM alters their function, rendering them proinflammatory. 27 In addition to targeting lung macrophages, PM has been shown to potentiate the antigen-presenting function of lung dendritic cells (DC). 28 The relative contribution of the respective APC type to the allergic airway inflammatory response induced by PM remains to be elucidated fully.
To investigate mechanisms by which PM exposure can target lung APCs to promote allergic diseases, we used a range of genetic, immunologic, and whole-animal approaches. Here we provide evidence for a critical role for PM-mediated, AhR-dependent Jag1 induction in AM in promoting allergic airway inflammation through a process involving Notch 4-dependent allergen-specific T H cell differentiation.
METHODS Mice

Il4ra
R576 and forkhead box p3 (Foxp3) EGFP mice were described previously. 15, 29, 30 The following mice were obtained from the Jackson Laboratory (Bar Harbor, Me): BALB/c (wild-type), Ahr fl/fl (Ahr 
Rag2
2/2 Il4ra R576 Foxp3 EGFP mice. 30 Jag1 fl/fl mice were kindly provided by Dr Freddy Radtke. 33 Particles UFP (< _0.18 mm) were collected in an urban area of downtown Los Angeles, as previously reported. 15 Constituent components of the particles were analyzed as described and are summarized in Table E1 in this article's Online Repository at www.jacionline.org. 34 The respective particles were suspended in an aqueous solution, with the hydrophilic components becoming part of the solution, whereas the solid nonsoluble UFP cores are left in suspension. The entire mixture was administered intranasally, as indicated below. 
T-cell cocultures with lung macrophages and DC
Il4ra
R576
Foxp3
EGFP mice by using fluorescein-activated cell sorting (FACS). AM and IM were isolated by means of FACS and placed in aliquots at 2 3 10 4 cells in 48-well plates and then either sham treated or treated overnight with UFP at 10 mg/mL. The UFP treatment did not induce increased apoptosis compared with sham treatment, as assessed by using Annexin V staining (data not shown). The APCs were washed twice with PBS to remove residual UFP, and the T cells were then added at 4 3 10 5 cells/well in a final volume of 0.5 mL of 10% FCS/RPMI culture medium. Cultures were treated with the ovalbumin (OVA) 323-339 peptide at 1 mmol/L, as indicated. Anti-murine Notch antibodies were added at 10 mg/mL each, as indicated.
Allergic sensitization and challenge
Mice were sensitized to OVA by means of intraperitoneal injection of 100 mg of OVA in 100 mL of PBS and then boosted 2 weeks later with a second intraperitoneal injection of OVA in PBS. Control mice were sham sensitized and boosted with PBS alone. Starting on day 29, both OVA-and sham-sensitized mice were challenged with aerosolized OVA at 1% for 30 minutes daily for 3 days. Two hours before each OVA aerosol exposure, subgroups of mice were intranasally administered either PBS or UFP at 10 mg/100 mL of PBS per instillation. For anti-Notch 4 antibody blocking, 150 mg of Armenian hamster anti-mouse Notch 4 IgG mAb (clone HMN4-14; Bio X Cell, Lebanon, NH) 35 or control Armenian hamster IgG polyclonal antibodies (Bio X Cell) was suspended in 100 mL of PBS buffer and administered daily for 3 consecutive days during OVA aerosol challenge. Mice were killed on day 32 after sensitization and analyzed. For dust mite-induced allergic airway inflammation, mice received 5 mg of lyophilized Dermatophagoides pteronyssinus extract (Greer Laboratories, Lenoir, NC) in 100 mL of PBS administered intranasally for 3 days at the start of the protocol and then challenged with the same dose of D pteronyssinus extract on days 15 to 17 with or without UFP. Mice were killed on day 18 and analyzed for measures of airway inflammation. Bronchoalveolar lavage (BAL) fluid and lung tissues were obtained and analyzed for cellular components and T-cell cytokine expression, according to previously published methods. 15, 30 For AM, IM, and DC cell transfer studies, cells were isolated from either Il4ra R576 or Il4ra
R576
Lyz2
Cre Jag1 D/D donor mice by using FACS. Cells were cultured overnight and either sham treated or loaded with OVA 323-339 peptide at 5 nmol/L peptide concentration either alone or together with UFP at 10 mg/mL. Cells were transferred intratracheally to OVA-sensitized Il4ra
R576
Lyz2
Cre Jag1 D/D recipient mice at 10 5 cells/mouse repeated twice over 2 days. The mice were killed on the third day and analyzed for the different parameters of allergic airway inflammation.
Lung histopathologic staining
Paraffin-embedded lung sections were stained with hematoxylin and eosin, as previously described. 36 Lung pathology was scored by blinded operators. Inflammation was scored separately for cellular infiltration around blood vessels and airways: 0, no infiltrates; 1, few inflammatory cells; 2, a ring of inflammatory cells 1 cell layer deep; 3, a ring of inflammatory cells 2 to 4 cells deep; and 4, a ring of inflammatory cells more than 4 cells deep. 37 A composite score was determined by adding inflammatory scores for both vessels and airways. Numbers and distribution of goblet cells were assessed by using periodic acid-Schiff (PAS) staining of mucin granules. Individual airways (bronchi/ bronchioles) were scored for goblet cell hyperplasia, according to the following scale: 0, no PAS-positive cells; 1, less than 5% PAS-positive cells; 2, 5% to 10% PAS-positive cells; 3, 10% to 25% PAS-positive cells; and 4, greater than 25% PAS-positive cells. 38 
Statistical analysis
The Student 2-tailed t test, 1-and 2-way ANOVA, and repeated-measures 2-way ANOVA with Bonferroni posttest analysis of groups were used to compare test groups, as indicated. A P value of less than .05 was considered statistically significant.
Study approval
All animal studies were reviewed and approved by the Boston Children's Hospital office of Animal Care Resources.
Other methods
Information about real-time PCR analysis, flow cytometry (including Fluoresbrite yellow green [YG] microspheres and nanobeads), intracellular staining reagents, antibodies and methods, IgE ELISA, and measurement of airway hyperresponsiveness is provided in the Methods section in this article's Online Repository at www.jacionline.org.
RESULTS
Lung macrophages are the major cellular target of UFP in the lungs under basal and inflammatory conditions
To further elucidate the role of the Jag1-AhR-Notch pathway in promotion of airway inflammation by UFP, we first sought to establish detailed immunophenotypic characterization of the APCs targeted by PM in our study model under both basal and especially allergic inflammatory conditions. We focused our studies on UFP, which are particularly toxic by virtue of their deep penetrance, large surface area/size ratios, higher content per mass of PAHs, and greater capacity to induce oxidative stress. 39, 40 We used an OVA-induced allergic airway inflammation model with Il4ra R576 mice. These mice carry an IL-4 receptor a chain (IL-4Ra-R576) variant that mediates exaggerated allergic airway inflammation to allergen, either alone or in combination with UFP, by virtue of mediating IL-4 receptor-dependent mixed T H 2/T H 17 cell inflammation. 15, 30 Mice were sensitized by means of intraperitoneal injection of OVA and then challenged with repeated inhalation of PBS (sham challenge) or 1% aerosolized OVA.
Subgroups of mice were treated intranasally with UFP in combination with Fluoresbrite YG nanobeads (0.05-mm effective diameter) or microspheres (1-mm effective diameter) 2 hours before the OVA aerosol challenge. 41 Nanobead fluorescencepositive cell populations were analyzed by using flow cytometry (Fig 1, A and B) . In the absence of inflammation (PBS-sensitized, OVA-treated group), 95% or greater nanobead-uptaking cells were CD45 42 In the context of allergic airway inflammation induced by OVA and especially by OVA plus UFP, about 85% of nanobead-uptaking cells were macrophages distributed at a 70:30 ratio between AM and IM (Fig 1,  A-C In agreement with their M2-like phenotype, in vitro treatment of cell-sorted AM with UFP sharply upregulated their production of the cytokines IL-10, CCL17, IL-6 and TNF-a but induced little change in their baseline production of IL-12 (see Fig E3, C) . 44, 45 Of the remaining beads (15%), about two thirds were picked up by CD11c Siglec-F low neutrophils (Fig 1, B and C, and see Fig E1) . These results indicate that AM and IM were the major cell subsets responsible for clearance of inhaled UFP in the context of allergic airway inflammation. Similar cellular localization results were obtained when Fluoresbrite YG microsphere beads were used instead of nanobeads, which is consistent with our previously published data showing FP and UFP sharing the same AhR-Notch-Jag1 mechanism of action in FIG 1. AM differentially uptake nanoparticles and highly express Jag1 in response to UFP. A and B, Flow cytometric analysis of the uptake of fluorescent nanoparticles by different lung cell populations in mice subjected to OVA plus UFP-induced allergic airway inflammation. C, Bar graph presentation of the distribution of nanoparticles among lung macrophages (AM and IM), DC, and neutrophils (Neu). D and E, Relative fold changes in Jag1 transcripts quantitated by using RT-PCR (Fig 1, D) and flow cytometric analysis of Jag1 expression (Fig 1, E) in lung APCs purified from either Il4ra R576 or Il4ra
R576
Lyz2
Cre Ahr D/D mice and treated with PBS or UFP (10 mg/mL). F and G, Relative fold changes in Jag1 transcripts (Fig 1, F) and Jag1 expression (Fig 1, G) in lung APCs purified from either l4ra R576 or Il4ra R576 Lyz2
Cre Jag1 D/D mice and treated with PBS or UFP, as described for Fig 1, D and E. Results are representative of 2 independent experiments (n 5 3 mice per group). *P < .05, **P < .01, ***P < .001, and ****P < .0001, 1-way ANOVA with posttest analysis (Fig 1, C , D, and F) or the Student unpaired 2-tailed t test (Fig 1, F 
UFP differentially induce Jag1 expression in lung AM
UFP induces Jag1 expression in an AhR-dependent manner in bone marrow2derived DC 15 and macrophages (see Fig E5, A, in this article's Online Repository at www.jacionline.org). We examined the expression of Jag1 transcripts in different APC populations isolated from the lungs of Il4ra R576 mice and either sham treated or treated in vitro with UFP. Jag1 expression was greatest at baseline values in AM compared with IM and DC (Fig 1, D) . In vitro treatment with UFP superinduced Jag1 transcript expression in AM, whereas the same treatment was associated with modest increases in IM and DC numbers (Fig 1, D) . In contrast, treatment with Fluoresbrite YG nanobeads did not induce Jag1 expression on AM (see Fig E2, A) and also did not affect airway inflammation induced by OVA despite the Fluoresbrite YG nanobeads localizing to AM when administered intranasally (see Fig E2, 
R576
Lyz2
Cre Ahr D/D mice and abolished its superinduction by UFP. Although a similar trend was also noted in the other cell types, there was partial sparing of Jag1 expression in DC. Flow cytometric analysis confirmed the heightened expression of Jag1 in AM compared with the other cell types and its downregulation on Ahr deletion (Fig 1, E) . UFP-induced Jag1 expression in bone marrow2derived macrophages was affected similarly by Lyz2
Cre -driven Ahr deletion (see Fig E5, A) . Furthermore, sensitization of mice with OVA followed by challenge with OVA and UFP resulted in preferential induction of Jag1 on AM compared with IM and DC, and this induction was reversed by Lyz2
Cre -driven Ahr deletion (see Fig E5, B) . These results were further ascertained after deletion of a floxed Jag1 gene in myeloid lineages using Lyz2
Cre (Il4ra
R576
Lyz2
Cre Jag1 D/D
; Fig 1, F and G). Jag1 transcript expression and Jag1 surface staining were completely abrogated in AM both at baseline and after UFP treatment. Reduced Jag1 transcript expression and Jag1 protein staining persisted in IM, whereas their levels were unaffected in DC. These findings confirmed AM as the principal APC cell type expressing Jag1 both at baseline and after UFP treatment and confirmed that this expression proceeds through an Ahr-dependent mechanism. They also showed that Lyz2
Cre preferentially targets Jag1 in macrophages, particularly AM, while largely sparing it in DC, which is consistent with previous lineage tracing analysis on the activity of Lyz2
Cre in macrophages versus DC.
47
UFP-treated AM promote T H cell differentiation in a Jag1-dependent mechanism
To examine whether induction of Jag1 expression in AM by UFP augments allergen-induced T H cell differentiation, we used an in vitro T H cell differentiation system involving naive DO11.10 1
CD4
1 T cells derived from DO11.10 
Foxp3
2 T cells of IL-17, IL-13, and IL-4 and, to a much lesser extent, IFN-g, as revealed by using flow cytometric staining (Fig 2 and see Fig E6 in this article's Online Repository at www.jacionline.org). Expression of the first 3 cytokines was markedly upregulated by addition of UFP (10 mg/mL), whereas that of IFN-g was downregulated, which is consistent with exaggerated T H 2/T H 17 skewing. 30 In contrast, induction of IL-17, IL-13, and IL-4 expression in DO11.10
1
CD4
1 T cells by OVA 323-339 was moderately inhibited, and their superinduction by UFP was abolished completely when Il4ra
R576
Lyz2
Cre
Jag1
D/D AM were used as APCs. IFN-g expression in those cocultures was also impaired profoundly (Fig 2, A and B) .
We also used the DO11.10 cell in vitro T H cell differentiation system to examine the effect of UFP treatment on the capacity of AM to support the differentiation of naive allergen-specific T cells into induced Treg cells. In the absence of UFP, OVA 323-339 -loaded AM drove the differentiation of up to 40% of naive Il4ra R576 DO11. 10 1 CD4 1 T cells into Foxp3 1 cell induced regulatory T (iTreg) cells. Treatment with UFP partially inhibited iTreg cell differentiation independent of Jag1 expression (Fig 3, A and B) . Critically, however, UFP treatment of OVA 323-339 peptide2presenting AM skewed the formed iTreg cells into secreting T H 2/T H 17 cell cytokines, including IL-4, IL-13, and IL-17, but not the T H 1 cytokine IFN-g. This skewing was largely reversed by deletion of Jag1 in AM (Fig 3, C and D) . These results indicate that UFP adversely affect allergen-specific iTreg cell differentiation, in part by destabilizing newly formed iTreg cells toward T H 2/T H 17 cell differentiation in a Jag1-dependent manner.
Jag1 deletion in myeloid lineages abolishes augmentation of allergic airway inflammation by UFP
To determine the role of Jag1 expression on AM in supporting UFP upregulation of allergic airway inflammation in vivo, we first used Lyz2
Cre to delete component genes of the Ahr-Jag1 genetic circuit in myeloid lineage cells. Accordingly, Il4ra
R576
Lyz2
Jag1
D/D and Il4ra R576 mice were sensitized by means of intraperitoneal injection of OVA and then challenged with inhalation of 1% aerosolized OVA. Control mice were sham sensitized with PBS and challenged with aerosolized OVA. Subgroups of mice were treated intranasally with UFP (10 mg per instillation) or PBS 2 hours before the OVA aerosol challenge. 41 Sensitization and challenge of Il4ra R576 mice with OVA resulted in a robust airway inflammatory response characterized by airway inflammation and hyperresponsiveness, eosinophilia, and T-cell infiltration in the BAL fluid; increased total and OVA-specific serum IgE responses; and augmented T H 2 and T H 17 cell responses (Fig 4, A-K) . It additionally induced Treg cell destabilization into T H 2/T H 17 cell like phenotypes (Fig 4, L-O ). All these parameters were markedly augmented by UFP exposure during the OVA challenge phase. OVA sensitization and challenge of Il4ra
R576
Lyz2
Cre Jag1 D/D mice also resulted in a robust allergic airway inflammatory response that was similar to that noted in OVA-sensitized and challenged Il4ra R576 mice. However, augmentation by UFP of all the J ALLERGY CLIN IMMUNOL VOLUME 142, NUMBER 4 aforementioned parameters of allergic airway inflammation was abrogated completely in Il4ra R576 Lyz2
Cre Jag1 D/D mice, indicating a requisite requirement for Jag1 expression in myeloid lineages for UFP to exert its proinflammatory effects in the airways (Fig 4, A-O) .
We also examined the role of Jag1 expression in myeloid lineage cells to mediate augmentation by UFP of allergic airway inflammation induced on intranasal treatment of Il4ra R576 mice with extracts of house mites (D pteronyssinus), a common and potent human allergen. Results were concordant with those observed with OVA sensitization and challenge. Whereas UFP augmented the airway inflammation induced by treatment of Il4ra R576 mice with a low dose of D pteronyssinus (5 mg), this effect was abrogated in Il4ra 1 APC lineages using CD11c
Cre did not inhibit the promotion of airway inflammation by UFP and in fact worsened it, indicating a unique 
Foxp3
1 iTreg cells (Fig 3, A and B) , and their expression of IL-4, IL-13, IL-17, and IFN-g (Fig 3, C-J) , on co-culture of naive Il4ra R576 CD4 1 DO11.10 1 T cells with FACS-purified AM isolated from Il4ra R576 or Il4ra
R576
Lyz2
Cre Jag1
mice. The AM that have been either sham treated (PBS) or pulsed with OVA 323-339 peptide either alone or in the presence of UFP, as indicated. Results are representative of 3 independent experiments. **P < .01, ***P < .001, and ****P < .0001, 2-way ANOVA with posttest analysis.
J ALLERGY CLIN IMMUNOL VOLUME 142, NUMBER 4 and specific requirement for Jag1 induction by UFP in AM for their acquisition of a proinflammatory function (see Fig E9 in this article's Online Repository at www.jacionline.org).
Jag1 expression in AM is sufficient to mediate UFP upregulation of allergic airway inflammation
To specifically establish the role of Jag1 expression in AM in exacerbation of allergen-induced airway inflammation by UFP, we examined the capacity of AM to rescue the UFP effect when transferred into Il4ra
R576
Lyz2
Cre Jag1 D/D mice. Accordingly, AM were isolated from either Il4ra R576 or Il4ra
R576
Lyz2
D/D mice, either sham treated or loaded with OVA 323-339 peptide, in the absence or presence of UFP. Cells were transferred into the airways of Il4ra
R576
Lyz2
Cre Jag1 D/D mice sensitized with OVA, which were then examined for induction of allergic airway inflammation. Results revealed that transfer of Jag1-sufficient OVA 323-339 peptide-pulsed and UFP-treated Il4ra R576 AM into OVA-sensitized Il4ra
R576
Lyz2
Cre Jag1 D/D mice recapitulated all the stigmata of exacerbated allergic airway inflammation induced by UFP, including augmented tissue inflammation, increased airway hyperresponsiveness, serum total and OVA-specific IgE levels, and BAL fluid CD4
1 T-cell infiltration and eosinophilia (Fig 5, A-G ). It also augmented T H cell cytokine production and 
R576
Lyz2
Cre Jag1 D/D mice in the PBS, OVA, or OVA plus UFP groups (3200 magnification).
B, Inflammation scores in lung tissue isolated from the mouse groups described in Fig 4, A. C-G, Airway hyperresponsiveness, expressed as resistance index (RI), in response to methacholine (Fig 4, C) , absolute numbers of eosinophils (Fig 4, D) and T cells (Fig 4, E) in BAL fluid, and total (Fig 4, F) and OVA-specific (Fig 4, G) levels in the serum of the mouse groups described in Fig 4, A. RI, Airway hyperresponsiveness. H-K, Absolute numbers of lung Foxp3 2 CD4 1 T cells secreting IL-4 (Fig 4, H) , IL-13 (Fig 4, I ), IL-17 (Fig 4, J) , and IFN-g (Fig 4, K) in the mouse groups described in Fig 4, A. L-O, Absolute numbers of lung Foxp3 1 CD4 1 Treg cells secreting IL-4 (Fig 4, L) , IL-13 (Fig 4, M) , IL-17 (Fig 4, N) , and IFN-g (Fig 4, O) in the mouse groups described in Fig 4, A. Results are representative of 2 independent experiments (n 5 5 mice per group). *P < .05, **P < .01, ***P < .001, and ****P < .0001, 2-way ANOVA with posttest analysis.
Treg cell destabilization into T H cell-like phenotypes (Fig 5,  H-O) . In contrast, transfer of similarly treated Jag1-deficient Il4ra
R576
Lyz2
Cre Jag1 D/D AM did not do so, indicating that Jag1 expression of AM is sufficient to restore the capacity of UFP to augment allergen-induced airway inflammation.
We also examined the capacity of IM and DC isolated from the lungs of Il4ra R576 or Il4ra R576 Lyz2
Cre Jag1 D/D mice and sham treated or loaded with OVA 323-339 or OVA 323-339 plus UFP to promote airway inflammation when transferred intratracheally into OVA-sensitized Il4ra R576 Lyz2
Cre Jag1 D/D mice. However, 
R576
Lyz2
Cre Jag1 D/D mice supplemented intratracheally with AM isolated from Il4ra R576 or Il4ra
R576
Lyz2
Cre Jag1 D/D mice that were either sham treated (PBS) or loaded with OVA 323-339 peptide (OVA) alone or together with UFP (OVA1UFP). B, Inflammation scores of lung tissues of mice described in Fig 5, A. C-G, Airway hyperresponsiveness (Fig 5, C) , numbers of eosinophils (Fig 5, D) and T cells (Fig 5, E) in BAL fluid, and total (Fig 5, F) and OVA-specific (Fig 5, G) levels in sera of mice described in Fig 5, A. RI, Airway hyperresponsiveness. H-K, Numbers of lung Foxp3
T cells secreting IL-4 (Fig 5, H) , IL-13 (Fig 5, I ), IL-17 (Fig 5, J) , and IFN-g (Fig 5, K) in BAL fluid of mice described in Fig 5, A. L-O, Numbers of lung Foxp3
1
CD4
1 Treg cells secreting IL-4 (Fig 5, L) , IL-13
( Fig 5, M) , IL-17 (Fig 5, N) , and IFN-g (Fig 5, O) in BAL fluid of mice described in Fig 5, A. Results are representative of 3 independent experiments (n 5 7-12 mice per group). *P < .05, **P < .01, ***P < .001, and ****P < .0001, 2-way ANOVA with Bonferroni posttest analysis. n.s., Not significant.
J ALLERGY CLIN IMMUNOL VOLUME 142, NUMBER 4 unlike the case of Jag1-sufficient AM, transferred IM did not promote allergic airway inflammation, irrespective of their treatment modality (see Fig E10, A-F in the Online Repository). The transferred DC also did not induce airway hyperresponsiveness. OVA 323-339 -loaded DC induced suboptimal tissue infiltration with eosinophils and T H cells compared with AM, which was not augmented by UFP treatment. These results are consistent with the unique role of Jag1-sufficient AM in promoting airway inflammation and in its superinduction by UFP (see Fig  E10, 
G-L).
Promotion by UFP of allergen-induced T H cell differentiation involves Jag1-Notch 4 interaction
We next determined the role of the respective Notch receptors in mediating the proinflammatory effects of Jag1 expressed by AM on UFP treatment. Accordingly, we first analyzed ex vivo expression of the different Notch receptors in FACS-purified CD4 1 enhanced green fluorescent protein (EGFP) 2 conventional T cells and CD4
1
EGFP
1 Treg cells isolated from Il4ra R576 Foxp3 EGFP mice. The cells were isolated from the spleens of unmanipulated mice and from the lungs of mice subjected to allergic airway inflammation without or with UFP cotreatment.
Splenic CD4
1 T cells primarily expressed Notch 1 and Notch 2 (data not shown), which is consistent with our previous results. 48 In contrast, Notch 4 expression was upregulated in CD4 1 T cells isolated from the lungs of mice sensitized with OVA and challenged with OVA plus UFP to become the highest among the 4 Notch receptors (see Fig E11 in this article' s Online Repository at www.jacionline.org). Notch 1 and Notch 2 expression was also upregulated, although to a lesser extent, whereas Notch 3 expression decreased.
Informed by the above results, we next used the in vitro coculture system described in Fig 2 to IL-17, IL-13, and IL-4 and, to much lesser extent, IFN-g, whereas this effect was abolished when Il4ra
R576
Lyz2
Cre Jag1 D/D AM were used as APCs. Critically, upregulation of T H cell cytokine expression by UFP, including IL-4, IL-13, and IL-17, was uniformly inhibited by cotreatment with a highly specific neutralizing anti-Notch 4 mAb (Fig 6 and see Fig E12 in this article's Online Repository at www.jacionline.org). 49 Anti-Notch 4 mAb also inhibited the residual IFN-g production induced by OVA alone or with UFP. In contrast, treatment with neutralizing mAbs specific for other Notch receptors produced partial and/or selective inhibitory results (see Fig E12) . Anti-Notch 4 mAb also suppressed production by DO11.10 R576 mice sensitized and challenged with OVA alone or together with UFP in the presence of either isotype control (Iso) antibodies (Ab) or an anti-Notch 4 mAb. B, Inflammation scores in lung tissues of mouse groups described in Fig 7, A. C-H, Airway hyperresponsiveness in response to methacholine (Fig 7, C) ; absolute numbers of eosinophils (Fig 7, D) , T cells (Fig 7, E) and neutrophils (Fig 7, F) in BAL fluid; and total (Fig 7, G) and OVA-specific (Fig 7, H ) levels in sera of the mouse groups described in Fig 7, A. RI, Airway hyperresponsiveness. I-L, Absolute numbers of lung Foxp3
2
CD4
1 T cells secreting IL-4 (Fig 7, I ), IL-13 (Fig 7, J) , IL-17 (Fig 7, K) , and IFN-g (Fig 7, L) in the mouse groups described in Fig 7, A. M-P, Absolute numbers of lung Foxp3
1
CD4
1 Treg cells secreting IL-4 (Fig 7, M) , IL-13 (Fig 7, N) , IL-17 (Fig 7, O) , and IFN-g (Fig 7, P) in the mouse groups described in panel Fig 7, A. Results are representative of 2 independent experiments (n 5 5 mice per group). *P < .05, **P < .01, ***P < .001, and ****P < .0001, 2-way ANOVA with posttest analysis. 
Notch 4 inhibition suppresses exacerbation of allergic airway inflammation by UFP
Given the efficacy of the neutralizing anti-Notch 4 mAb in reversing augmented in vitro differentiation of allergenspecific T H cells induced by UFP treatment of allergen peptide-presenting AM, we examined the effect of inhibiting Notch 4 on exacerbation of the allergic airway inflammatory response induced by UFP. Accordingly, Il4ra R576 mice sensitized and challenged with OVA alone or together with UFP were treated with either an anti-Notch 4 or isotype control mAb during the challenge phase and then analyzed for the various parameters of the airway allergic inflammatory response. In vivo, treatment with the anti-Notch 4 mAb had little or no effect on OVA-induced allergic airway inflammation in terms of tissue inflammation, airway hyperresponsiveness, BAL fluid eosinophilia, serum total and OVA-specific IgE responses, and airway T H 2 and T H 17 cell responses. In contrast, it completely inhibited the potentiation of the aforementioned parameters induced by UFP, thus implicating Notch 4 in mediating the potentiating effects of UFP on allergic airway inflammation (Fig 7, A-G) .
DISCUSSION
Our previous studies have demonstrated that traffic-related PM, including UFP and FP, promotes allergic airway inflammation by inducing Jag1 expression on APCs in an AhR-dependent manner, which in turn activates Notch signaling to augment T H cytokine expression by allergenspecific T cells. 15 In this study we identified AM as the key target of PM by virtue of their avid uptake of nanoparticles and microparticles and their superinduction of Jag1 expression on PM uptake compared with other lung APCs. We have also identified Notch 4 on T cells as a key mediator of the Jag1-dependent upregulation by UFP-treated AM of allergen-specific T H cell differentiation and iTreg cell destabilization. Notch 4 inhibition with a neutralizing anti-Notch 4 mAb completely abrogated the upregulation by UFP of allergic airway inflammation. Thus these studies established cellular elements, including AM and allergenspecific CD4
1 T H and Treg cells, and molecular effectors, including Jag1 and Notch 4, involved in mediating the proinflammatory effects of the PM-activated AhR-Jag1-Notch circuit in the setting of allergic airway inflammation.
AM have been implicated in the homeostatic maintenance of tolerance in the airways by virtue of their downregulation of the antigen-presenting capacity of DC, 50 as well as their promotion of iTreg cell differentiation. 23 AM are also less effective in presenting antigens compared with DC, a defect that could be overcome by provision of an accessory signal, such as costimulation of T cells with CD28 or IL-2. 51, 52 Upregulation of Jag1 expression in AM by PM-mediated activation of AhR can enable efficient antigen presentation with Jag1-Notch acting as a coreceptor pair that amplifies T H cell cytokine production. 53 Our results clearly demonstrate a necessary and sufficient role for Jag1-sufficient AM to rescue augmentation by UFP of allergic airway inflammation in mice lacking Jag1 in their myeloid lineages. Under inflammatory conditions, increased uptake of nanoparticles by IM was noted, possibly reflecting in part the increased abundance of the latter cells in inflamed lung tissues and/or their heightened avidity for these particles. Nevertheless, reconstitution of Il4ra R576 Lyz2
Cre Jag1 D/D mice with either IM or DC did not rescue the inflammatory responses to UFP, which is indicative of the requisite role of Jag1-sufficient AM in this process.
Although deletion of Jag1 on AM reversed UFP-induced augmentation of allergic airway inflammation, it also attenuated a few parameters of allergen-induced airway inflammation in the absence of UFP, such as mobilization of CD4 1 T cells in lung tissues (Figs 4 and 5) . These findings argue that residual Jag1 expression on AM can contribute to allergen-induced airway inflammation in the absence of UFP treatment and that UFP act to greatly amplify this process.
A surprising finding in our studies was the identification of Notch 4 as a key Notch receptor through which UFP mediated their effects in upregulating allergic airway inflammation. Notch 4 inhibition provided effective and uniform suppression of UFP and AM-dependent in vitro differentiation of allergen-specific T cells into different T H cell subsets. In contrast, inhibition of other Notch receptors, including Notch 1 and 2, provided selective and/or partial inhibition of T H cell cytokine expression. Notch 4 inhibition also suppressed exacerbation by UFP of allergic airway inflammation in mice. The NOTCH4 locus has been associated previously with severe asthma, 54 suggesting that this pathway can modulate disease severity, especially as it relates to environmental exposures, such as exposure to UFP.
The mechanisms by which Notch 4 can contribute selectively to allergic airway inflammation are currently unclear. Jag1 expressed on AM can interact preferentially with Notch 4 compared with other Notch receptors. Alternatively or in parallel, Notch 4 can act to differentially amplify production of T H cell cytokines or possibly instruct their specific production compared with other Notch receptors by means of Notch canonical and noncanonical signaling mechanisms. 53, 55 Notch 4 signaling also destabilized differentiation of iTreg cells, leading to production of T H cell cytokines. Such an iTreg cell phenotype is associated with decreased suppressive function and lineage instability, potentially leading to the terminal differentiation of Treg cells into T H cell lineages. 30, 56 Our previous studies have documented an inhibitory function of Notch signaling in Treg cells in controlling their regulatory functions. 48 The differential contribution of Jag1-Notch 4 signaling in allergen-specific T H versus iTreg cells in mediating disease exacerbation by UFP remains to be determined. Also unclear is whether Notch 4 signaling in Treg cells plays a unique and nonredundant role in regulating their function compared with other Notch receptors. Distinct and dedicated functions of different Notch receptors in T H and Treg cell populations in allergic airway inflammation can offer opportunities for targeted therapeutic interventions. Finally, and in addition to targeting T cells, a neutralizing Notch 4 mAb can act in vivo to modulate additional cellular elements, such as the vascular endothelium, involved in mobilizing the airway inflammatory response. 57, 58 Future studies will be required to delineate the respective contributions of these mechanisms to UFP-promoted allergic airway inflammation.
Key messages
d Lung AM are a key target of traffic-related PM in promoting allergic airway inflammation.
d Traffic-related UFP induce expression of the Notch ligand Jag1 on AM through AhR.
d Jag1 on AM interacts with Notch 4 on naive allergenspecific T cells to promote T H 2 and T H 17 cell differentiation.
d Treatment with an anti-Notch 4 mAb abrogates exacerbation of allergic airway inflammation induced by UFP.
METHODS Reagents
The AhR ligand 6-formylindolo (3,2-b) carbazole was purchased from Santa Cruz Biotechnology (Dallas, Tex). Lyophilized dust mite (D pteronyssinus) whole-body extract was obtained from Greer Laboratories. Fluoresbrite YG microspheres (1.00 mm diameter) and nanobeads (0.05 mm diameter) were bought from Polysciences (Warrington, Pa). For some experiments, mice were intranasally administered Fluoresbrite YG microspheres or nanobeads alone (10 mg/100 mL of PBS per instillation) or the mixture of microspheres or nanobeads with UFP at a 1:1 ratio (10 mg of microspheres or nanobeads plus 10 mg of UFP in 100 mL of PBS instillation).
Real-time PCR analysis
Lung AM, IM, and DC were purified by using cell sorting from the respective donor mouse strain. They were treated further with either PBS (sham) or 10 mg/mL UFP for 12 hours. Total RNA was collected for target gene analysis. Il4ra
R576
Foxp3
EGFP mice, which were described in earlier publications, E1,E2 were used for analysis of Notch receptor expression on T cells. Briefly, Il4ra
R576
Foxp3
EGFP mice were sensitized and boosted with 100 mg of OVA in 100 mL of PBS by means of intraperitoneal injection. Starting on day 29, OVA-sensitized mice were challenged with aerosolized OVA at 1% for 30 minutes daily for 3 days. Two hours before each OVA aerosol exposure, subgroups of mice received intranasal administration of either PBS or UFP at 10 mg/100 mL of PBS per instillation. After challenge, lung tissues were collected and digested with 1 mg/mL Collagenase IV for 2 hours. CD3
1 CD4 1 Foxp3 EGFP1 and CD3
EGFP2 cells from lungs or spleens (control) were purified by means of cell sorting based on EGFP expression. cDNA was reverse transcribed from 2 mg of RNA per sample and used in real-time PCR assays that used TaqMan (Applied Biosystems, Foster City, Calif). The comparative cycle threshold (Ct) method normalized to glyceraldehyde-3-phosphate dehydrogenase was used to analyze relative changes in gene expression. The fold change was calculated as 22 2DDCt for DDCt values (indicating a fold change).
Antibodies, flow cytometry, and intracellular staining
Single-cell suspensions were stained with the indicated antibodies and analyzed on the LSRIIFortessa cytometer (Becton Dickinson, San Jose, Calif). Cytokine expression in CD4 1 T cells was determined by stimulating cells with phorbol 12-myristate 13-acetate (20 ng/mL) plus ionomycin (1 mg/mL) for 4 hours in the presence of Golgi-Plug (BD Biosciences), followed by intracellular staining for the respective cytokine with the eBioscience Fixation/Permeabilization buffer (eBioscience, San Diego, Calif), according to the manufacturer's instructions. Fluorescence-conjugated mAbs were obtained from BD Biosciences, BioLegend (San Diego, Calif), and eBioscience. Anti-CD3-fluorescein isothiocyanate, phycoerythrin (PE)-Cy7, peridininchlorophyll-protein complex (PerCP)-Cy5.5 (145 2C11), anti-CD4-Alexa Fluor 700 (GK1.5), anti-CD8-PerCP-Cy5.5 (53-6.7), anti-B220-allophycocyanin (RA3-6B2), anti-F4/80-Pacific Blue (BM8), anti-CD11b-PerCPCy5.5 (M1/70), anti-MHC class II-I-Ad (39-10-8), anti-Notch 2-PE (HMN2-35), E3 anti-Notch 4-Alexa Fluor 647 (HMN4-14), E3 anti-CD45-Alexa Fluor 700 (30-F11), and Annexin V apoptosis detection kit were purchased from BioLegend. Anti-CD4-eFluor 450 (GK1.5), anti-CD19-fluorescein isothiocyanate (6D5), anti-Gr-1-PerCP-Cy5.5 (RB6-8C5), anti-IL-4-PE-CF594 (11B11, BD), anti-IL-13-PE (eBio13A), anti-IL-17-PE-Cy7 (eBio17B7), anti-IFN-g-allophycocyanin (XMG1.2), anti-Jag1-PE (HMJ1-29) anti-Notch 1-allophycocyanin (22E5), anti-Notch 3-APC (HMN3-133), and anti-CD11c-PE-Cy7 (N418) were obtained from eBioscience. Anti-Siglec-F-PE (E50-2440) was purchased from BD Biosciences.
For Notch neutralization experiments, mouse IgG 2b anti-Notch 1 mAb (A6), E4 rabbit polyclonal anti-Notch 2 (no. PA5-47091), and goat polyclonal anti-Notch 3 (no. PA5-47120) antibodies were purchased from Thermo Fisher (Waltham, Mass). Armenian hamster anti-mouse Notch 4 IgG mAb and control Armenian hamster IgG polyclonal antibodies were purchased from Bio X Cell.
E3
IgE and T H cytokine ELISAs
Total and OVA-specific IgE concentrations were measured by using sandwich ELISAs, as previously described. E5 Culture supernatants of PBSand UFP-treated AM were collected at 48 hours after incubation of cellsorted AM with UFP at 10 mg/mL. They were assayed for IL-6, IL-10, IL-12 p40, TNF-a, and CCL17 by using ELISA with detection kits purchased from eBioscience (IL-6, IL-10, and TNF-a), BioLegend (IL-12 p40), and R&D Systems (Minneapolis, Minn; CCL17).
Measurement of airway hyperresponsiveness
Airway resistance was measured 24 hours after the last day of OVA or OVA/ UFP challenge. Mice were anesthetized and instrumented for measurement of pulmonary mechanics (BUXCO Electronics, Wilmington, NC), as previously detailed. E2 Baseline lung resistance and responses to aerosolized saline (0.9% NaCl) were measured first, followed by responses to increasing doses (0.32-10 mg/mL) of aerosolized acetyl-b-methylcholine chloride (methacholine; Sigma-Aldrich, St Louis, Mo). The 3 highest values of lung resistance obtained after each dose of methacholine were averaged to obtain the final values for each dose.
UFP sampling methodology
UFP were collected at the particle instrumentation unit of the University of Southern California by using a high-volume ultrafine sampler operating at a volumetric flow rate of about 400 L/min, as described in Saffari et al. E6 This sampling location is in the vicinity (ie, about 150 m downwind) of a major Los Angeles freeway and is thus primarily affected by vehicular emissions. UFP were collected on preweighted 8 3 11-inch Zeflour filter media (supported PTFE; Pall Life Sciences, Port Washington, NY) to determine mass concentrations, as well as concentrations of chemical species. After collection, filters were equilibrated overnight and postweighted under controlled laboratory conditions. Water-soluble elemental content was quantified by extracting a portion of the filters in ultrapure Milli-Q water (by using vortexing and sonication), and measurements were performed with a high-resolution sector field inductively coupled plasma mass spectrometer (SF-ICP-MS, Thermo Finnigan Element 2). E7 Organic carbon was also quantified with the Shimadzu VSH total organic carbon analyzer (Shimadzu, Kyoto, Japan).
E8
The chemical composition of the UFP used in the experiments is shown in Table E1 . Organic carbon represents a mixture of primary traffic emission and bulk oxygenated organic compounds, the abundance of which is an indicator of the extent of secondary organic aerosol formation and accounts for the majority of the UFP mass. E9 Concentrations of organic carbon and selected trace elements, metals, and PAHs in the UFP fractions used in these studies are shown in Table E1 . 1 lung cell populations (Fig E1, A) and in lung macrophage populations segregated by the markers F4/80 and CD11c (Fig E1, A) , followed by CD11b and CD11c (Fig E1, B) , in mice subjected to allergic airway inflammation. C-G, Distribution of nanobeads in the CD45 
CD11c
Hi AM cells (Fig E3, A) (Fig E3, B) were stained for the markers CD64, CD38, Egr2, and MHC class II I-A d , as indicated. Results are representative of 2 independent experiments (n 5 3 per group per experiment). C, Production of IL-6, IL-10, IL-12 p40 subunit, TNF-a, and CCL17 by cell-sorted AM treated in vitro for 48 hours with UFP at 10 mg/mL (n 5 5 independent cultures per cytokine assay). ****P < .0001, Student 2-tailed t test. 
FIG E7.
Myeloid lineage-specific deletion of Jag1 confers protection against the exacerbation by UFP of allergic airway inflammation induced by dust mites (DM). A, Representative PAS-stained sections of lung isolated from Il4ra R576 or Il4ra
R576
Lyz2
Cre Jag1 D/D mice in the PBS, DM, or DM plus UFP groups. B, Inflammation scores in lung tissues isolated from the mouse groups described in Fig E7, A. C-E, Absolute numbers of eosinophils (Fig E7, C) and T cells (Fig E7, D) in BAL fluid and serum total IgE concentrations ( Fig  E7, E) in the mouse groups described in Fig E7, A. F-I, Absolute numbers of lung Foxp3 2 CD4 1 T cells secreting IL-4 ( Fig E7, F) , IL-13 ( Fig E7, G) , IL-17 ( Fig E7, H) , and IFN-g (Fig E7, I ) in the mouse groups described in Fig E7, A. J-M, Absolute numbers of lung Foxp3 1 CD4 1 Treg cells secreting IL-4 ( Fig E7, J) , IL-13 ( Fig E7, K) , IL-17 ( Fig E7, L) , and IFN-g (Fig E7, M) in the mouse groups described in Fig E7, A. Results are representative of 2 independent experiments (n 5 5 mice per group). *P < .05, **P < .01, ***P < .001, ****P < .0001, 2-way ANOVA with posttest analysis.
FIG E8.
Myeloid lineage-specific deletion of Ahr confers protection against UFP-induced exacerbation of allergic airway inflammation. A, Representative PAS-stained sections of lung tissue isolated from Il4ra
R576
or Il4ra
Lyz2
Cre Ahr1 D/D mice in the PBS, OVA, or OVA plus UFP groups. B, Inflammation scores in lung tissues isolated from the mouse groups described in Fig E8, A. C-F, Absolute numbers of eosinophils (Fig E8, C) and T cells (Fig E8, D) in BAL fluid and serum total (Fig E8, E) and OVA-specific (Fig E8, F) IgE concentrations in the mouse groups described in Fig E8, A. G-J, Absolute numbers of lung Foxp3
T cells secreting IL-4 ( Fig E8, G) , IL-13 ( Fig E8, H) , IL-17 ( Fig E8, I) , and IFN-g (Fig E8, J) in the mouse groups described in Fig E8, A. K-N, Absolute numbers of lung Foxp3 1 CD4 1 Treg cells secreting IL-4 ( Fig E8, K) , IL-13
( Fig E8, L) , IL-17 ( Fig E8, M) , and IFN-g (Fig E8, N) in the mouse groups described in panel Fig E8, A. Results are representative of 2 independent experiments (n 5 5 mice per group). *P < .05, **P < .01, ***P < .001, and ****P < .0001, 2-way ANOVA with posttest analysis.
FIG E9. CD11c
Cre -mediated deletion of Jag1 does not protect against exacerbation by UFP of allergic airway inflammation induced by DM. A, Representative PAS-stained sections of lung tissue isolated from Il4ra R576 or Il4ra
R576
CD11c
Cre Jag1 D/D mice in the PBS, OVA, or OVA plus UFP groups. B, Inflammation scores in lung tissues isolated from the mouse groups described in Fig E9, A. C-F, Absolute numbers of eosinophils (Fig E9, C) and T cells (Fig E9, D) in BAL fluid and serum total and OVA-specific IgE concentrations ( Fig E9, E and F ) in the mouse groups described in Fig E9, A. Results are representative of 2 independent experiments (n 5 5 mice per group). **P < .01, ***P < .001, and ****P < .0001, 2-way ANOVA with posttest analysis.
FIG E10. Jag1-sufficient IM and DC do not rescue UFP-mediated allergic airway inflammation in Il4ra
R576
Lyz2
Cre Jag1 D/D mice. A-F, IM transfer. G-L, DC transfer. Airway hyperresponsiveness in response to methacholine (Fig E10, A and G) , absolute numbers of eosinophils ( Fig E10, B and H RI, Resistance index. *P < .05 and ***P < .001, 2-way ANOVA with Bonferroni posttest analysis. T cells cocultured with FACS-purified AM isolated from l4ra
R576 or Il4ra
R576
Lyz2
Cre Jag1 D/D mice either sham pulsed (PBS) or pulsed with OVA 323-339 peptide either alone (OVA) or in the presence of UFP (OVA1UFP) is shown, as indicated. Control or anti-Notch antibodies (Ab) were added as indicated. Results represent means 6 SEMs of 6 replicates derived from two independent experiments. **P < .01, ***P < .001, and ****P < .0001, 1-way ANOVA with posttest analysis. 
